Option Care Health (NASDAQ:OPCH) Issues FY25 Earnings Guidance

Option Care Health (NASDAQ:OPCH - Get Free Report) updated its FY25 earnings guidance on Monday. The company provided earnings per share guidance of $1.59-1.69 for the period, compared to the consensus earnings per share estimate of $1.32. The company issued revenue guidance of $5.2-5.4 billion, compared to the consensus revenue estimate of $5.24 billion. Option Care Health also updated its FY 2024 guidance to 1.550-1.590 EPS.

Option Care Health Price Performance

Shares of Option Care Health stock traded up $3.73 during trading on Monday, hitting $27.72. The stock had a trading volume of 5,926,688 shares, compared to its average volume of 2,114,090. The firm has a market cap of $4.72 billion, a price-to-earnings ratio of 23.29, a P/E/G ratio of 2.43 and a beta of 1.31. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The business's 50-day moving average is $23.10 and its 200 day moving average is $27.69. Option Care Health has a 12 month low of $21.39 and a 12 month high of $34.63.

Analysts Set New Price Targets

A number of brokerages recently weighed in on OPCH. Barrington Research lowered their target price on shares of Option Care Health from $40.00 to $32.00 and set an "outperform" rating on the stock in a research note on Thursday, October 31st. Jefferies Financial Group downgraded shares of Option Care Health from a "buy" rating to a "hold" rating and dropped their price objective for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and increased their target price for the company from $26.00 to $33.00 in a research note on Monday. UBS Group started coverage on Option Care Health in a research note on Thursday, December 5th. They set a "neutral" rating and a $26.00 price target for the company. Finally, The Goldman Sachs Group lowered Option Care Health from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $38.00 to $27.00 in a research report on Monday, November 4th. Three analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, Option Care Health currently has an average rating of "Moderate Buy" and a consensus price target of $29.71.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the business's stock in a transaction on Friday, November 8th. The shares were acquired at an average cost of $22.54 per share, with a total value of $969,220.00. Following the transaction, the director now owns 326,334 shares in the company, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. 0.64% of the stock is currently owned by insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.